Diagnostica Stago

Paris, France Founded: 1998 • Age: 28 yrs Acquired By Hemosonics
A portfolio of hemostasis and coagulation diagnostic products is manufactured.

About Diagnostica Stago

Diagnostica Stago is a company based in Paris (France) founded in 1998 was acquired by Hemosonics in May 2017.. The company has 7 employees as of April 06, 2024. Diagnostica Stago has completed 1 acquisition, including Hemosonics. Diagnostica Stago offers products and services including ST Genesia, My Expert QC, and sthemO. Diagnostica Stago operates in a competitive market with competitors including Accriva Diagnostics, Enzyre, Entegrion, Perosphere and Microvisk, among others.

  • Headquarter Paris, France
  • Employees 7 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Stago India Private Limited
  • Date of Incorporation 18 Jan, 2013
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $578.45 K (USD)
    5.2
    as on Mar 31, 2019
  • Net Profit
    $38.1 K (USD)
    144.64
    as on Mar 31, 2019
  • EBITDA
    $96.28 K (USD)
    -18.84
    as on Mar 31, 2019
  • Latest Funding Round
  • Investors
  • Employee Count
    7

    as on Apr 06, 2024

  • Investments & Acquisitions
  • Acquired by
    Hemosonics

    (May 30, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Diagnostica Stago

Diagnostica Stago offers a comprehensive portfolio of products and services, including ST Genesia, My Expert QC, and sthemO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Coagulation analyzer for advanced hemostasis testing in clinical settings

Tool for comparing internal quality control results across instruments

Range of reagents and devices for thrombosis and coagulation needs

Funding Insights of Diagnostica Stago

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Diagnostica Stago

Diagnostica Stago has secured backing from 1 investor. Prominent investors backing the company include Hemosonics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
IVD for hemostasis characterization
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Diagnostica Stago

Diagnostica Stago has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Hemosonics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
IVD for hemostasis characterization
2004
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Diagnostica Stago

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Diagnostica Stago Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Diagnostica Stago

Diagnostica Stago operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Enzyre, Entegrion, Perosphere and Microvisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Near-patient diagnostic systems for coagulation testing are developed.
domain founded_year HQ Location
Smart diagnostics devices for blood coagulation analysis are developed.
domain founded_year HQ Location
Hemostasis and fluid replacement products are provided for medical applications.
domain founded_year HQ Location
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
domain founded_year HQ Location
Handheld devices for blood clot monitoring are provided by Microvisk.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Diagnostica Stago

Frequently Asked Questions about Diagnostica Stago

When was Diagnostica Stago founded?

Diagnostica Stago was founded in 1998.

Where is Diagnostica Stago located?

Diagnostica Stago is headquartered in Paris, France.

How many employees does Diagnostica Stago have?

As of Apr 06, 2024, the latest employee count at Diagnostica Stago is 7.

What is the annual revenue of Diagnostica Stago?

Annual revenue of Diagnostica Stago is $578.45K as on Mar 31, 2019.

What does Diagnostica Stago do?

Diagnostica Stago was founded in 1998 and is headquartered in Paris, France. Operations focus on the hemostasis and coagulation sector, where in vitro diagnostic tests, instruments, reagents, and software solutions are developed. The product range includes factor assays, screening tests, control plasmas, and tools for assessing thrombophilia and fibrinolysis. Qualiris, a proficiency testing program, is maintained for routine and specialized hemostasis evaluations.

Who are the top competitors of Diagnostica Stago?

Diagnostica Stago's top competitors include Accriva Diagnostics, MedicQuant ApS and Enzyre.

What products or services does Diagnostica Stago offer?

Diagnostica Stago offers ST Genesia, My Expert QC, and sthemO.

How many acquisitions has Diagnostica Stago made?

Diagnostica Stago has made 1 acquisition, including Hemosonics.

Who are Diagnostica Stago's investors?

Diagnostica Stago has 1 investor. Key investors include Hemosonics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available